Physician profile
James Chmiel
NPI 1508810581
$29,883.25
in general payments reported to CMS, 2019-2025
9 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Sleep Medicine (Otolaryngology) provider received nationally (typical 2025 total: $509).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $13K · 2021: $1,113 · 2022: $277 · 2023: $405 · 2024: $506 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $21,022.56 | 2019-2021 | |
| Acclarent, INC | $7,661.24 | 2019-2024 | Trudi Nav Cable, Acclarent Navwire |
| Integra Lifesciences Corporation | $490.07 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $197.08 | 2025 | |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Nucala |
| Intersect Ent, INC. | $105.92 | 2020 | |
| Optinose US, INC. | $98.57 | 2019 | |
| Smith+Nephew, INC. | $93.47 | 2019 | |
| Stryker Corporation | $89.35 | 2023 | Xpress Ent Dilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Chmiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.